Testing effectiveness (Phase 2)Study completedNCT00940225What this trial is testingStudy of Cabozantinib (XL184) in Adults With Advanced MalignanciesWho this might be right forSolid TumorsCancer Exelixis 730
Testing effectiveness (Phase 2)Study completedNCT04208958What this trial is testingStudy of VE800 and Nivolumab in Patients With Selected Types of Advanced or Metastatic CancerWho this might be right forMetastatic CancerMelanomaGastric Cancer+2 more Vedanta Biosciences, Inc. 56
Large-scale testing (Phase 3)Looking for participantsNCT04997837What this trial is testingStudy of Adjuvant Chemotherapy With or Without PD-1 Inhibitors and Chemoradiotherapy in Resected pN3 Gastric (G) or GEJ AdenocarcinomaWho this might be right forGastric Cancer Fudan University 433
Testing effectiveness (Phase 2)Looking for participantsNCT06985602What this trial is testingAdebrelimab With Chemoradiotherapy and Surgery for G/GEJWho this might be right forGastroesophageal AdenocarcinomaGastric Adenocarcinoma Jiangsu Cancer Institute & Hospital 30
Large-scale testing (Phase 3)Study completedNCT05008783What this trial is testingAK104 in the First-line Treatment of Locally Advanced Unresectable or Metastatic G/GEJ AdenocarcinomaWho this might be right forGastric AdenocarcinomaGastroesophageal Junction Adenocarcinoma Akeso 610
Early research (Phase 1)UnknownNCT05315830What this trial is testingHER2 Tumor Vaccine in Patients With Her-2 Positive Gastric/GEJ Adenocarcinoma EsophagogastricWho this might be right forAdenocarcinoma - GEJAdenocarcinoma of the Stomach The First Affiliated Hospital of Bengbu Medical University 10
Testing effectiveness (Phase 2)Looking for participantsNCT04895709What this trial is testingBMS-986340 as Monotherapy and in Combination With Nivolumab or Docetaxel in Participants With Advanced Solid TumorsWho this might be right forCervical CancerGastric/Gastroesophageal Junction AdenocarcinomaMicrosatellite Stable Colorectal Cancer+8 more Bristol-Myers Squibb 949
Early research (Phase 1)Study completedNCT03821233What this trial is testingA Dose Finding Study of ZW49 in Patients With HER2-Positive CancersWho this might be right forHER2-expressing Cancers Zymeworks BC Inc. 112
Large-scale testing (Phase 3)Study completedNCT02545504What this trial is testingAndecaliximab With mFOLFOX6 as First Line Treatment for Advanced Gastric or Gastroesophageal Junction AdenocarcinomaWho this might be right forGastric Adenocarcinoma Gilead Sciences 432
Testing effectiveness (Phase 2)UnknownNCT05466019What this trial is testingA Prospective, Single Center Clinical Study of Toripalimab Combined With FLOT Regimen for Perioperative Treatment of PD-L1 Positive Locally Advanced Resectable Gastric Cancer or Gastroesophageal Junction Adenocarcinoma (GEJ)Who this might be right forPD-L1 Positive Locally Advanced Patients With Resectable Gastric Cancer The First Hospital of Jilin University 30
Large-scale testing (Phase 3)Study completedNCT02581462What this trial is testingFLOT vs. FLOT/Herceptin/Pertuzumab for Perioperative Therapy of HER-2 Expressing Gastric or GEJ CancerWho this might be right forStomach CancerGastroesophageal Junction Cancer Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest 81
Testing effectiveness (Phase 2)WithdrawnNCT03704077What this trial is testingAn Investigational Immuno-therapy Study of Relatlimab Plus Nivolumab Compared to Various Standard-of-Care Therapies in Previously Treated Participants With Recurrent, Advanced or Metastatic Gastric Cancer or Gastroesophageal Junction AdenocarcinomaWho this might be right forGastric CancerCancer of the StomachStomach Cancer+1 more Bristol-Myers Squibb
Large-scale testing (Phase 3)Not Yet RecruitingNCT07068516What this trial is testingPerioperative Tislelizumab Plus Chemotherapy Versus Chemotherapy Alone in MHC-II-Positive Gastric/GEJ CancerWho this might be right forGastric Cancer Stage Xiangdong Cheng 470
Testing effectiveness (Phase 2)Study completedNCT03918499What this trial is testingIRX-2, Cyclophosphamide, and Pembrolizumab in Treating Participants With Recurrent or Metastatic Gastric or Gastroesophageal Junction CancerWho this might be right forClinical Stage IV Gastric Cancer AJCC v8Clinical Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8Clinical Stage IVA Gastric Cancer AJCC v8+15 more City of Hope Medical Center 9
Not applicableLooking for participantsNCT07389876What this trial is testingAlbumin-bound Paclitaxel-based Second-line Treatment Regimens for Locally Advanced or Metastatic G/GEJ AdenocarcinomaWho this might be right forGastric CancerSecond-line Treatment Fudan University 250
Testing effectiveness (Phase 2)Active Not RecruitingNCT05190445What this trial is testingCinrebafusp Alfa in Combination With Ramucirumab and Paclitaxel in HER2-High Gastric or GEJ Adenocarcinoma and in Combination With Tucatinib in HER2-Low Gastric or GEJ AndenocarinomaWho this might be right forHER2-positive Gastric Cancer Pieris Pharmaceuticals, Inc. 80
Early research (Phase 1)Ended earlyNCT03407976What this trial is testingApatinib With Pembrolizumab in Previously Treated Advanced MalignanciesWho this might be right forAdvanced MalignanciesUrothelial CarcinomaMSI-H or dMMR Solid Tumors+1 more University of Utah 5
Large-scale testing (Phase 3)Active Not RecruitingNCT06351020What this trial is testingLM-302 for the Treatment of Subjects With Claudin18.2-Positive Gastric and Gastroesophageal Junction Adenocarcinoma.Who this might be right forLocally Advanced or Metastatic GC and GCJ Adenocarcinoma LaNova Medicines Zhejiang Co., Ltd. 387
Testing effectiveness (Phase 2)Ended earlyNCT05071053What this trial is testingTusamitamab Ravtansine (SAR408701) in Combination With Ramucirumab in Pretreated Participants With Gastric CancerWho this might be right forAdenocarcinoma GastricGastrooesophageal Cancer Sanofi 35
Not applicableStudy completedNCT04281576What this trial is testingEffect of Tumor Treating Fields (TTFields, 150 KHz) Concomitant with Chemotherapy As First Line Treatment of Unresectable Gastroesophageal Junction or Gastric AdenocarcinomaWho this might be right forGastric CancerGastroEsophageal Cancer NovoCure Ltd. 28